Phlegmasia Cerulea Dolens as A Complication of Severe Pneumonia Because Of SARS Cov-2 |Biomedgrid

Novel Coronavirus Disease 2019 (COVID-19) is a global pandemic with more than 4 million positive cases across the globe. Recent retrospective studies suggest an increased risk for venous thromboembolism in patients with COVID-19. We report a case of a woman with a phlegmasia cerulean dolens as a complication of severe pneumonia because of SARS-CoV-2, probably related to diagnosis delay. Phlegmasia cerulea dolens is a manifestation of massive venous thrombosis associated with a high amputation rate, pulmonary embolism, and a mortality rate of over 40%. Emergency physicians should be aware of these complications when evaluating a patient with COVID-19.